Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Andreas Faldum et al.|Clinical Cancer Research|2014Cited by 99